We bring commercial life sciences experience, proprietary technology assets, and the best talent to help you modernize your CRM the right way. This is your chance to redefine the future of customer engagement for your organization.
Reimagining engagement
The pharmaceutical sector is preparing for a forced change that will require organizations to update their customer relationship management platform (CRM) in the coming years. To be successful in the impending transformation of your pharmaceutical technology platforms, you need a collaborator that can handle complexity, deliver results with trust and transparency, and enable a business-centric technology change. We share your mission to help make patients healthier, and we are ready to join you on your journey.
Pharmaceutical companies now have the rare, once-in-a-generation opportunity to step back and examine their CRM. This is a moment to dig in and reimagine what's possible.
How we can help
Despite the challenges and disruption that a forced CRM change can bring, innovating now will be less difficult than innovating later. No matter how your business approaches customer engagement transformation, your success is dependent on it being technology-led and harnessing the right CRM, data, and AI tools with a collaborator you trust. A modernized CRM ensures no wasted interactions with customers, allowing your organization to see positive results with our framework approach below.
No matter where you fall in your transformation timeline, our teams are ready to dive in and help you get your CRM, AI, and data future-ready.
01
Strategy
01
Strategy
If you’re just beginning to think about your future customer engagement strategy and life sciences CRM transformation, we’ll help you define your vision and think through all potential considerations to build alignment within your organization and anticipate marketplace trends.
02
CRM technology and vendor assessment
02
CRM technology and vendor assessment
As you consider platform options, our team will help you determine what your unique technology needs are and provide vendor comparisons.
03
Organizational and technology readiness
03
Organizational and technology readiness
Once we’ve established your customer engagement strategy and capability needs, we’ll help get you ready to kickstart the implementation of these changes by ensuring technological readiness and alignment across the organization.
04
Implementation and deployment
04
Implementation and deployment
Our team will work side by side with you to deploy your CRM platform with your selected vendor technologies and manage the associated organizational, business, and program management changes that come with your implementation.
05
Operations
05
Operations
Once your transformation is in flight, we’ll handle the ongoing management of your new life sciences CRM platform, manage updates, and own the day-to-day operations in the collaborative capacity that works best for you.
Our Team
Patricia Gee
Patricia leads Deloitte’s Future of Health initiative in Switzerland. She has spent over 15 years in the life science and health industry, bringing together cross-sector experience in biopharma, payer, provider and capital markets. She focuses on driving sustainable value, growth and innovation for leading life science clients by creating commercial portfolio and business unit strategies, designing and developing customer-centric solutions and deploying commercial excellence programs.
Gabriele Vanoli
Gabriele is a Partner in Monitor Deloitte’s Life Sciences Strategy practice with focus on Commercial Transformation. Gabriele brings 20 years of management consulting experience in Life Sciences across mature and emerging countries, including more than 10 years at BCG and 4 years at EY where he was leading the Life science commercial practice. He has served most of the top global pharmaceutical companies and a range of mid-size, specialty and biotech clients.
Michael Balling
Michael is a partner in the Deloitte’s EMEA Life Sciences practice. He drives transformation projects powered by commercial technology platforms that enable scaled HCP and patient omnichannel engagement. Michael is passionate about how technology can be used to optimise the HCP and patient experience, and support clients in defining their customer engagement model and translating this into the required capabilities and technology. He has over 15 years of experience in delivering large-scale technology transformations in the pharmaceutical, generics, and medtech industry, primarily related to the Veeva and Salesforce ecosystems. Michael leads Deloitte’s Salesforce industry alliance and partnership in EMEA.